1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of
diabetes: estimates for the year 2000 and projections for 2030.
Diabetes Care. 2004;27(5):1047–1053.
2. Chatterjee S, Peters SA, Woodward M, et al. Type 2 diabetes as a
risk factor for dementia in women compared with men: a pooled
analysis of 2.3 million people comprising more than 100,000 cases
of dementia. Diabetes Care. 2016;39(2):300–307.
3. Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus
and risk of dementia: a meta-analysis of prospective observational
studies. J Diabetes Investig. 2013;4(6):640–650.
4. Ninomiya T. Diabetes mellitus and dementia. Curr Diab Rep.
2014;14(5):487.
5. Matsui Y, Tanizaki Y, Arima H, et al. Incidence and survival of
dementia in a general population of Japanese elderly: the Hisayama
study. J Neurol Neurosurg Psychiatry. 2009;80(4):366–370.
6. Okamura H, Ishii S, Ishii T, Eboshida A. Prevalence of dementia
in Japan: a systematic review. Dement Geriatr Cogn Disord. 2013;
36(1–2):111–118.
7. Abellan van Kan G, Rolland Y, Nourhashemi F, Coley N, Andrieu
S, Vellas B. Cardiovascular disease risk factors and progression of
Alzheimer’s disease. Dement Geriatr Cogn Disord. 2009;27(3):
240–246.
8. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA.
Diabetes mellitus and risk of Alzheimer disease and decline in
cognitive function. Arch Neurol. 2004;61(5):661–666.
9. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk
factors and Alzheimer’s disease in later life: longitudinal, population
based study. BMJ. 2001;322(7300):1447–1451.
10. Kawamura T, Umemura T, Hotta N. Cognitive impairment in
diabetic patients: Can diabetic control prevent cognitive decline?
J Diabetes Investig. 2012;3(5):413–423.
11. Biessels GJ, Kamal A, Ramakers GM, et al. Place learning and
hippocampal synaptic plasticity in streptozotocin-induced diabetic
rats. Diabetes. 1996;45(9):1259–1266.
Liu Z, et al.
12. Brownlee M. Biochemistry and molecular cell biology of diabetic
complications. Nature. 2001;414(6865):813–820.
13. Geijselaers SLC, Sep SJS, Stehouwer CDA, Biessels GJ. Glucose
regulation, cognition, and brain MRI in type 2 diabetes: a systematic
review. Lancet Diabetes Endocrinol. 2015;3(1):75–89.
14. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of
dementia. N Engl J Med. 2013;369(6):540–548.
15. Euser SM, Sattar N, Witteman JC, et al. A prospective analysis of
elevated fasting glucose levels and cognitive function in older
people: results from PROSPER and the Rotterdam Study. Diabetes.
2010;59(7):1601–1607.
16. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in
cognitive abilities over a 4-year period are unfavorably affected in
elderly diabetic subjects: results of the Epidemiology of Vascular
Aging Study. Diabetes Care. 2001;24(2):366–370.
17. Fuh JL, Wang SJ, Hwu CM, Lu SR. Glucose tolerance status and
cognitive impairment in early middle-aged women. Diabet Med.
2007;24(7):788–791.
18. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in
cognitive function by glucose tolerance status in older adults: a
4-year prospective study of the Rancho Bernardo study cohort. Arch
Intern Med. 2004;164(12):1327–1333.
19. Ueshima H, Kadowaki T, Hisamatsu T, et al. Lipoprotein-associated
phospholipase A2 is related to risk of subclinical atherosclerosis but
is not supported by Mendelian randomization analysis in a general
Japanese population. Atherosclerosis. 2016;246:141–147.
20. Zaid M, Fujiyoshi A, Miura K, et al. High-density lipoprotein
particle concentration and subclinical atherosclerosis of the carotid
arteries in Japanese men. Atherosclerosis. 2015;239(2):444–450.
21. Fujiyoshi A, Miura K, Kadowaki S, et al. Lifetime cigarette smoking
is associated with abdominal obesity in a community-based sample
of Japanese men: the Shiga Epidemiological Study of Subclinical
Atherosclerosis (SESSA). Prev Med Rep. 2016;4:225–232.
22. Nakamura M, Sato S, Shimamoto T. Improvement in Japanese
clinical laboratory measurements of total cholesterol and HDLcholesterol by the US Cholesterol Reference Method Laboratory
Network. J Atheroscler Thromb. 2003;10(3):145–153.
23. Kashiwagi A, Kasuga M, Araki E, et al. International clinical
harmonization of glycated hemoglobin in Japan: From Japan
Diabetes Society to National Glycohemoglobin Standardization
Program values. J Diabetes Investig. 2012;3(1):39–40.
24. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities
Screening Instrument (CASI): a practical test for cross-cultural
epidemiological studies of dementia. Int Psychogeriatr. 1994;6(1):
45–58; discussion 62.
25. World Health Organization IDF. Definition and diagnosis of
diabetes mellitus and intermediate hyperglycaemia: A report of
WHO=IDF consultation. Geneva, Switzerland: WHO Document
Production Services; 2006.
26. Kaplan RJ, Greenwood CE, Winocur G, Wolever TM. Cognitive
performance is associated with glucose regulation in healthy elderly
persons and can be enhanced with glucose and dietary carbohydrates. Am J Clin Nutr. 2000;72(3):825–836.
27. Xu W, Qiu C, Winblad B, Fratiglioni L. The effect of borderline
diabetes on the risk of dementia and Alzheimer’s disease. Diabetes.
2007;56(1):211–216.
28. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ.
Diabetes and other vascular risk factors for dementia: which factor
matters most? A systematic review. Eur J Pharmacol. 2008;585(1):
97–108.
29. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk
of dementia in diabetes mellitus: a systematic review. Lancet Neurol.
2006;5(1):64–74.
30. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and
dementia in diabetes—systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460–2469.
31. Ohara T, Doi Y, Ninomiya T, et al. Glucose tolerance status and risk
of dementia in the community: the Hisayama study. Neurology.
2011;77(12):1126–1134.
32. Yaffe K, Falvey CM, Hamilton N, et al. Association between
hypoglycemia and dementia in a biracial cohort of older adults with
diabetes mellitus. JAMA Intern Med. 2013;173(14):1300–1306.
33. Yamaguchi S, Meguro K, Ishii H, Meguro M, Akanuma K.
Assessment of mental deterioration with the Cognitive Abilities
Screening Instrument (CASI) and glucose hypometabolism in
Alzheimer’s disease: the Osaki-Tajiri Project. J Clin Neurosci.
2009;16(11):1430–1434.
34. Friederici AD. The brain basis of language processing: from
structure to function. Physiol Rev. 2011;91(4):1357–1392.
J Epidemiol 2020;30(3):121-127
127
...
論文の公開元へ
